---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-024096"
form_type: "8-K"
ticker: "ANEB"
cik: "0001815974"
company_name: "Anebulo Pharmaceuticals, Inc."
filed_at: "2024-06-17T23:59:59+00:00"
generated_at: "2026-06-01T04:09:20.760184+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Anebulo adopts new non-employee director equity compensation policy

## Summary
- Initial grant of option to purchase 50,000 shares, vesting monthly over 3 years.
- Annual grant of option to purchase 25,000 shares, vesting 1 year or next annual meeting.
- All options expire 10 years from grant date.

## SEC filing metadata
- accession: 0001493152-24-024096
- form_type: 8-K
- ticker: ANEB
- cik: 0001815974
- company_name: Anebulo Pharmaceuticals, Inc.
- filed_at: 2024-06-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1815974/000149315224024096/0001493152-24-024096-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1815974/000149315224024096/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-024096
- JSON: https://secwatch.observer/filing/0001493152-24-024096.json
- Plain text: https://secwatch.observer/filing/0001493152-24-024096.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.